- Home
- LYRA vs IPDN Comparison
LYRA vs IPDN Comparison
Compare LYRA & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- IPDN
- Stock Information
- Founded
- LYRA 2005
- IPDN 2003
- Country
- LYRA United States
- IPDN United States
- Employees
- LYRA N/A
- IPDN 43
- Industry
- LYRA Medical/Dental Instruments
- IPDN EDP Services
- Sector
- LYRA Health Care
- IPDN Technology
- Exchange
- LYRA Nasdaq
- IPDN Nasdaq
- Market Cap
- LYRA 7.6M
- IPDN 9.1M
- IPO Year
- LYRA 2020
- IPDN 2013
- Fundamental
- Price
- LYRA $3.88
- IPDN $1.89
- Analyst Decision
- LYRA Hold
- IPDN
- Analyst Count
- LYRA 1
- IPDN 0
- Target Price
- LYRA $16.00
- IPDN N/A
- AVG Volume (30 Days)
- LYRA 30.6K
- IPDN 611.0K
- Earning Date
- LYRA 11-12-2025
- IPDN 11-14-2025
- Dividend Yield
- LYRA N/A
- IPDN N/A
- EPS Growth
- LYRA N/A
- IPDN N/A
- EPS
- LYRA N/A
- IPDN N/A
- Revenue
- LYRA $600,000.00
- IPDN $6,497,046.00
- Revenue This Year
- LYRA N/A
- IPDN N/A
- Revenue Next Year
- LYRA $106.28
- IPDN N/A
- P/E Ratio
- LYRA N/A
- IPDN N/A
- Revenue Growth
- LYRA N/A
- IPDN N/A
- 52 Week Low
- LYRA $3.69
- IPDN $0.97
- 52 Week High
- LYRA $37.50
- IPDN $12.39
- Technical
- Relative Strength Index (RSI)
- LYRA 22.62
- IPDN 31.25
- Support Level
- LYRA $5.40
- IPDN $1.96
- Resistance Level
- LYRA $4.80
- IPDN $2.55
- Average True Range (ATR)
- LYRA 0.42
- IPDN 0.38
- MACD
- LYRA -0.17
- IPDN -0.10
- Stochastic Oscillator
- LYRA 7.39
- IPDN 1.57
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.